Recent Price Movement and Market Context
Poly Medicure’s share price has been under pressure for the past week, declining by 3.82% compared to a modest 0.63% fall in the Sensex over the same period. Over the last month, the stock dropped 1.92%, while the Sensex gained 2.27%. Year-to-date, the stock has fallen sharply by 28.58%, in stark contrast to the Sensex’s 8.91% rise. Over the last year, the stock’s performance has been particularly disappointing, with a 34.20% decline against the Sensex’s 4.15% gain. Despite this, the stock has delivered strong long-term returns, rising 97.56% over three years and 271.21% over five years, outperforming the benchmark significantly in those periods.
On the day in question, the stock traded close to its 52-week low, just 1.85% above the lowest price of ₹1,822.65. It touched an intraday low of ₹1,850, reflecting selling pressure throughout the session. The weighted average price indicated that most volume was traded near the day’s low, signalling bearish sentiment. Furthermore, Poly Medicure is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—highlighting a sustained downtrend. This decline is in line with the broader Medical Equipment/Supplies/Accessories sector, which fell by 2.29% on the day.
Investor participation has also waned, with delivery volumes on 05 Dec falling by nearly 32% compared to the five-day average, suggesting reduced buying interest. Despite this, liquidity remains adequate for moderate trade sizes, with the stock’s average traded value supporting transactions of around ₹0.26 crore.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Fundamental Factors and Valuation Challenges
Poly Medicure’s fundamentals present a mixed picture. The company maintains a low debt-to-equity ratio, effectively zero, which is a positive indicator of financial stability. Institutional investors hold a significant 23.31% stake, reflecting confidence from knowledgeable market participants. The company is a major player in its sector, with a market capitalisation of ₹19,331 crore, making it the second largest in the Medical Equipment/Supplies/Accessories industry and accounting for 17.71% of the sector’s market value. Its annual sales of ₹1,712.13 crore represent nearly 16% of the industry’s total sales, underscoring its market presence.
However, recent operational metrics have raised concerns. The company reported flat results in September 2025, with a notably low dividend payout ratio of 10.70%, which may disappoint income-focused investors. Additionally, the debtors turnover ratio for the half-year period stands at a low 4.02 times, indicating slower collection of receivables and potential working capital inefficiencies.
Valuation appears stretched, with a return on equity of 12.4% paired with a high price-to-book ratio of 6.4. While the stock’s valuation is broadly in line with historical averages for its peers, the price-earnings-to-growth (PEG) ratio of 2.3 suggests the market is pricing in significant growth expectations. This is despite the stock’s negative total return of 34.20% over the past year, even as profits increased by 22.8%, indicating a disconnect between earnings growth and share price performance.
The stock’s underperformance relative to the broader market is stark. While the BSE500 index generated a modest 0.62% return over the last year, Poly Medicure’s shares have declined substantially, reflecting investor caution and possibly concerns over near-term growth prospects and valuation.
Holding Poly Medicure from Healthcare Services? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: Why Poly Medicure Is Falling
Poly Medicure’s recent share price decline is primarily driven by its underwhelming short-term performance relative to the broader market and sector peers. Despite solid long-term returns and profit growth, the stock has struggled to maintain investor confidence amid flat quarterly results, low dividend payouts, and operational inefficiencies such as a sluggish debtors turnover ratio. The high valuation multiples, particularly the price-to-book and PEG ratios, suggest that the market has priced in elevated growth expectations, which the company has yet to fully deliver in terms of share price appreciation.
Additionally, the stock’s technical indicators, including trading below all major moving averages and declining investor participation, reinforce the bearish sentiment. The sector’s own weakness has compounded these pressures, resulting in a sustained downtrend for Poly Medicure’s shares. Investors appear cautious, weighing the company’s strong market position and institutional backing against its recent performance challenges and valuation concerns.
For those considering exposure to the healthcare equipment sector, it may be prudent to evaluate alternative opportunities that offer more attractive valuations or stronger near-term growth prospects.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
